HomeInsightsStock Comparison

Astonea Labs Ltd vs Balaxi Pharmaceuticals Ltd Stock Comparison

Astonea Labs Ltd vs Balaxi Pharmaceuticals Ltd Stock Comparison

Last Updated on: Jun 14, 2025

Key Highlights

  • The Latest Trading Price of Astonea Labs Ltd is ₹ 141.25 as of 13 Jun 15:30.
  • The P/E Ratio of Astonea Labs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Market Cap of Astonea Labs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 74 crore on March 2020 to ₹ 2702 crore on March 2024 . This represents a CAGR of 105.35% over 5 years.
  • The revenue of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 74.57 crore as compare to the Dec '24 revenue of ₹ 77.23 crore. This represent the decline of -3.44%.
  • The ebitda of Astonea Labs Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Balaxi Pharmaceuticals Ltd for the Mar '25 is ₹ 10.86 crore as compare to the Dec '24 ebitda of ₹ 7.93 crore. This represent the growth of 36.95%.
  • The net profit of Astonea Labs Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ -41.34 crore to ₹ 8.64 crore over 8 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Astonea Labs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2024 . This represents a CAGR of -100.00% over 3 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Astonea Labs Ltd

  • Astonea Labs Ltd was originally incorporated as 'AHU Laboratories Private Limited', as a private limited company, pursuant to certificate of incorporation dated April 11, 2017.
  • Company changed its name from AHU Laboratories Limited to 'Astonea Labs Private Limited' dated February 26, 2019.
  • Subsequently, the Company converted into 'Astonea Labs Limited', vide fresh Certificate of Incorporation dated January 11, 2024. Company specializes in the manufacturing and marketing of a wide range of pharmaceutical and cosmetic products.
  • These include antibiotic drugs, anticold medications, antihistamines, and drugs for diabetes, cardiovascular diseases, gynecological concerns, analgesics, fungal infections, and multivitamins.
  • These are used for skin, tooth, and hair care, available in various forms such as gels, ointments, creams, lotions, oils, and serums.

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

Astonea Labs Ltd News Hub

News

BSE SME Astonea Labs inches higher on debut

The scrip was listed at Rs 137.45, a premium of 1.81% compared with the initial public off...

Read more

03 Jun 2025 11:01

Balaxi Pharmaceuticals Ltd News Hub

News

Balaxi Pharmaceuticals AGM scheduled

Balaxi Pharmaceuticals announced that the 82th Annual General Meeting(AGM) of the company ...

Read more

02 Jun 2025 10:41

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 30 ...

Read more

22 May 2025 19:48

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 ...

Read more

03 Feb 2025 10:51

News

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 N...

Read more

30 Oct 2024 16:58

News

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company ...

Read more

01 Aug 2024 12:52

News

Balaxi Pharmaceuticals to convene board meeting

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 2 A...

Read more

26 Jul 2024 10:45

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Balaxi Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of null and Balaxi Pharmaceuticals Ltd

Which company has a larger market capitalization, Astonea Labs Ltd or Balaxi Pharmaceuticals Ltd?

Market cap of Astonea Labs Ltd is 148 Cr while Market cap of Balaxi Pharmaceuticals Ltd is 287 Cr

What are the key factors driving the stock performance of Astonea Labs Ltd and Balaxi Pharmaceuticals Ltd?

The stock performance of Astonea Labs Ltd and Balaxi Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astonea Labs Ltd and Balaxi Pharmaceuticals Ltd?

As of June 14, 2025, the Astonea Labs Ltd stock price is INR ₹141.25. On the other hand, Balaxi Pharmaceuticals Ltd stock price is INR ₹51.99.

How do dividend payouts of Astonea Labs Ltd and Balaxi Pharmaceuticals Ltd compare?

To compare the dividend payouts of Astonea Labs Ltd and Balaxi Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions